ASCO® 2023 Insights: "Efficacy and Safety Results From the Ph3 COMMANDS Trial - Evaluating Luspatercept vs. Epoetin Alfa in ESA‑Naïve Transfusion-Dependent Pts With LR-MDS" | VuMedi

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

10 seconds

Playback speed

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Efficacy and Safety Results From the Ph3 COMMANDS Trial - Evaluating Luspatercept vs. Epoetin Alfa in ESA‑Naïve Transfusion-Dependent Pts With LR-MDS"

By Insights from 2023 ASCO® Annual Meeting FEATURING Matteo Della Porta

By Insights from 2023 ASCO® Annual Meeting FEATURING Matteo Della Porta

274 views

June 14, 2023

Comments 0

Login to view comments. Click here to Login